Professional Documents
Culture Documents
Approach To The Management of Gallstones - UpToDate
Approach To The Management of Gallstones - UpToDate
Close
This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies.
edback
Accept or find out more
Contents
Calculators
Drug Interactions
UpToDate Pathways
Menu
Medical Professional
●
Resident, Fellow, or Student
●
Hospital or Institution
●
Group Practice
●
Subscribe
■ Elective cholecystectomy
■ Alternatives to cholecystectomy
❍ Asymptomatic gallstones
■ Expectant management
RAPHICS
●
Algorithms
❍ Management of gallstones
ELATED TOPICS
● Acalculous cholecystitis: Clinical manifestations, diagnosis, and management
● Acute calculous cholecystitis: Clinical features and diagnosis
● Acute cholangitis: Clinical manifestations, diagnosis, and management
INTRODUCTION
The presence of gallstones (cholelithiasis) is common, particularly in Western
populations. In the United States, gallstones are seen in approximately 6 percent of
men and 9 percent of women [1]. Most individuals with gallstones are asymptomatic
throughout their life and gallstones are found incidentally. The approach to the
management of patients with gallstones depends upon the patient's symptoms,
imaging test findings, and whether complications are present.
This topic will review the approach to the patient with uncomplicated gallstones. The
discussion that follows is generally consistent with guidelines from the National
Institute for Health and Care Excellence [2]. Separate topic reviews on gallstone
disease and its complications include the following:
● (See "Gallstones: Epidemiology, risk factors and prevention".)
● (See "Overview of gallstone disease in adults".)
● (See "Acute calculous cholecystitis: Clinical features and diagnosis".)
● (See "Treatment of acute calculous cholecystitis".)
● (See "Acalculous cholecystitis: Clinical manifestations, diagnosis, and
management".)
● (See "Choledocholithiasis: Clinical manifestations, diagnosis, and
management".)
● (See "Acute cholangitis: Clinical manifestations, diagnosis, and management".)
● (See "Mirizzi syndrome".)
● (See "Gallstone ileus".)
● (See "Clinical manifestations and diagnosis of acute pancreatitis".)
TERMINOLOGY
● Gallstone disease – The term gallstone disease refers to gallstones that
cause symptoms.
● Uncomplicated gallstone disease – The term uncomplicated gallstone
disease refers to stones in the gallbladder that are associated with biliary colic
in the absence of complications. (See "Overview of gallstone disease in adults",
section on 'Complications'.)
We use ketorolac (30 to 60 mg adjusted for age and renal function given in a single
intravenous or intramuscular dose) for patients who present to the emergency
department with biliary colic. Treatment usually relieves symptoms within 10 to 30
minutes. Patients are then prescribed oral NSAIDs (eg, ibuprofen 400 mg) for
subsequent attacks that may occur while the patient is awaiting cholecystectomy.
Patients who are managed as outpatients should be instructed to report to the
emergency department if the pain does not resolve within four hours of the start of the
pain because they are then at risk for developing complications such as acute
cholecystitis. (See "Treatment of acute calculous cholecystitis", section on 'Pain
control' and 'Elective cholecystectomy' below.)
The role of NSAIDs in the treatment of biliary colic was demonstrated in a meta-
analysis of 11 randomized trials with 1076 patients that compared NSAIDs with no
treatment, placebo, or other treatments [3]. The NSAIDs studied included ketorolac,
diclofenac, tenoxicam, flurbiprofen, and ketoprofen. NSAIDs were more likely to
control pain than placebo (relative risk [RR] 3.8; 95% confidence interval [CI] 1.7-8.6)
or antispasmodics (RR 1.5; 95% CI 1.0-2.1). There was no difference in pain control
between NSAIDs and opioids (RR 1.1; 95% CI 0.8-1.3). NSAIDs may also favorably
alter the natural history of biliary colic, possibly due to the role of prostaglandins in the
development of acute cholecystitis [4,5]. (See "Acute calculous cholecystitis: Clinical
features and diagnosis", section on 'Epidemiology'.)
It was traditionally thought that meperidine is the narcotic of choice in patients with
biliary colic or gallstone pancreatitis because it has less of an effect on sphincter of
Oddi motility than morphine [6-8]. However, all opioids result in increased sphincter of
Oddi pressure [7]. There are insufficient data to suggest that morphine should be
avoided. Morphine has an advantage that it requires less frequent dosing than
meperidine, which has a shorter half-life. (See "Treatment of acute calculous
cholecystitis", section on 'Pain control'.)
Subsequent management
We refer patients for cholecystectomy after an isolated attack of biliary colic even
though approximately a third of patients with a first episode of biliary colic will not
develop a recurrence within two years [10]. The rationale for our approach is that
some patients may have unrecognized recurrent attacks if the initial attacks were not
severe enough to have prompted medical attention.
laparoscopic cholecystectomy".)
Patients should be educated about the symptoms of biliary colic and instructed to
seek medical attention if symptoms develop. In addition, patients should undergo
evaluation of stone type, size, and gallbladder function to determine if they are
candidates for oral dissolution therapy. (See "Overview of gallstone disease in
adults", section on 'Biliary colic' and "Overview of nonsurgical management of
gallbladder stones", section on 'Management'.)
Asymptomatic gallstones
Patients at increased risk for gallbladder cancer include those with one of the
following [12,13]:
• Anomalous pancreatic ductal drainage (in which the pancreatic duct drains
into the common bile duct) (see "Biliary cysts", section on 'Abnormal
pancreatobiliary junction and cancer').
also important to note that symptoms may change over time and patients with
continued symptoms should be carefully reassessed, paying specific attention to the
type of ongoing symptoms and if biliary colic has developed [23].
Patients who fail to respond to ursodiol should instead be treated for disorders more
consistent with their symptoms (eg, functional dyspepsia in a patient with bloating).
(See "Functional dyspepsia in adults", section on 'Management'.)
GALLSTONES IN PREGNANCY
The approach to women with gallstones who are pregnant is discussed in detail
elsewhere. (See "Gallstones in pregnancy".)
Here are the patient education articles that are relevant to this topic. We encourage
you to print or e-mail these topics to your patients. (You can also locate patient
education articles on a variety of subjects by searching on "patient info" and the
keyword(s) of interest.)
● Basics topics (see "Patient education: Gallstones (The Basics)" and "Patient
education: Gallbladder removal (cholecystectomy) (The Basics)")
● Beyond the Basics topics (see "Patient education: Gallstones (Beyond the
Basics)")
● For patients with typical biliary colic and gallstones on imaging, we recommend
REFERENCES
1. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in
gallbladder disease in the United States. Gastroenterology 1999; 117:632.
6. Elta GH, Barnett JL. Meperidine need not be proscribed during sphincter of
Oddi manometry. Gastrointest Endosc 1994; 40:7.
8. Thune A, Baker RA, Saccone GT, et al. Differing effects of pethidine and
morphine on human sphincter of Oddi motility. Br J Surg 1990; 77:992.
9. Dimou FM, Adhikari D, Mehta HB, Riall TS. Trends in Follow-Up of Patients
Presenting to the Emergency Department with Symptomatic Cholelithiasis. J
Am Coll Surg 2016; 222:377.
12. Leitzmann MF, Rimm EB, Willett WC, et al. Recreational physical activity and
the risk of cholecystectomy in women. N Engl J Med 1999; 341:777.
13. Leitzmann MF, Giovannucci EL, Rimm EB, et al. The relation of physical activity
to risk for symptomatic gallstone disease in men. Ann Intern Med 1998; 128:417.
14. Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA 1983;
250:2323.
15. BATES GC, BROWN CH. Incidence of gallbladder disease in chronic hemolytic
anemia (spherocytosis). Gastroenterology 1952; 21:104.
16. Bond LR, Hatty SR, Horn ME, et al. Gall stones in sickle cell disease in the
United Kingdom. Br Med J (Clin Res Ed) 1987; 295:234.
17. Reiss R, Nudelman I, Gutman C, Deutsch AA. Changing trends in surgery for
acute cholecystitis. World J Surg 1990; 14:567.
18. Capocaccia L, the GREPCO group. Clinical symptoms and gallstone disease:
Lessons from a population study. In: Epidemiology and prevention of gallstone
disease, Capocaccia L, Ricci G, Angelico F, Attili AF (Eds), Lancaster MTP
Press, 1984. p.153.
19. Barbara L, Sama C, Morselli Labate AM, et al. A population study on the
20. Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent
gallstone is not a myth. N Engl J Med 1982; 307:798.
21. Shiffman ML, Sugerman HJ, Kellum JM, et al. Gallstone formation after rapid
weight loss: a prospective study in patients undergoing gastric bypass surgery
for treatment of morbid obesity. Am J Gastroenterol 1991; 86:1000.
22. Wattchow DA, Hall JC, Whiting MJ, et al. Prevalence and treatment of gall
stones after gastric bypass surgery for morbid obesity. Br Med J (Clin Res Ed)
1983; 286:763.
23. Karmacharya A, Malla BR, Joshi HN, et al. The predictive value of pre-operative
symptoms including upper gastrointestinal endoscopy before laparoscopic
cholecystectomy for elective symptomatic cholecystolithiasis. Kathmandu Univ
Med J (KUMJ) 2013; 11:300.
24. Berger MY, Olde Hartman TC, Bohnen AM. Abdominal symptoms: do they
disappear after cholecystectomy? Surg Endosc 2003; 17:1723.
25. Thistle JL, Longstreth GF, Romero Y, et al. Factors that predict relief from upper
abdominal pain after cholecystectomy. Clin Gastroenterol Hepatol 2011; 9:891.
● Language
● Help
● Language
● Help
● Subscription and License Agreement
● Policies
● Support Tag
● Contact Us
● About Us
● UpToDate News
● Mobile Access
● Training Center
● Demos